CRISPR/Cas9‑mediated hypoxia inducible factor‑1α knockout enhances the antitumor effect of transarterial embolization in hepatocellular carcinomaQuan Liu(Guangzhou Institutes of Biomedicine and Health), Li‐Ping Liu(Jinan University)Oncology ReportsAugust 23, 201810.3892/or.2018.6667Cited by 28SaveCiteExport RISWatch citationsRelated Papers<i>Plasmodium</i> parasite as an effective hepatocellular carcinoma antigen glypican-3 delivery vector|Oncotarget|2017|43